Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003147889 | SCV003835315 | uncertain significance | Intellectual disability, X-linked 93 | 2022-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003164866 | SCV003887569 | uncertain significance | Inborn genetic diseases | 2023-05-08 | criteria provided, single submitter | clinical testing | The c.3724A>G (p.I1242V) alteration is located in exon 32 (coding exon 32) of the BRWD3 gene. This alteration results from an A to G substitution at nucleotide position 3724, causing the isoleucine (I) at amino acid position 1242 to be replaced by a valine (V). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |